Afuco™ Anti-Human FCGR2B ADCC Therapeutic Antibody (SM201), ADCC Enhanced

Anti-FCGR2B ADCC Enhanced Antibody (SM201) is an ADCC enhanced antibody produced by our Afuco™ platform. SM201 is an anti-hFcγRIIB antibody not interfering with ligand binding that mediates immune complex dependent inhibition of B cells, it can be used for the treatment of antibody-mediated autoimmune diseases.
Supplier Creative Biolabs
Product # AFC-255CL
Pricing Inquiry
Host Human
Target FCGR2B
Species Reactivity Human
Type ADCC enhanced antibody
Storage Store at –20 or -70°C upon receipt. Divide antibody into aliquots prior usage and avoid multiple freeze-thaw cycles.
Feedback